STUDY COMPARISON OF EFFICACY OF LEVETIRACETAM ANDMAGNESIUM SULPHATE IN THE MANAGEMENT OF ANTEPARTUM, INTRAPARTUM AND POSTPARTUM CONVULSIONS
Phase 2
- Conditions
- Health Condition 1: O159- Eclampsia, unspecified as to timeperiod
- Registration Number
- CTRI/2021/04/032963
- Lead Sponsor
- Dr Sindhu Manne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ALL PATIENTS PRESENTING WITH FEATURES OF ECLAMPSIA DURING THE SAID PERIOD WILL BE RECRUITED INTO THE STUDY
ALL PATIENTS GIVING INFORMED AND WRITTEN CONSENT FOR INVESTIGATIONS
Exclusion Criteria
PATIENTS WHO WERE DIAGNOSED WITH OTHER CAUSES OF CONVULSIONS IN PREGNANCY LIKE CEREBRAL MALARIA AND EPILEPSY
CHRONIC HYPERTENSIVE PREGNANT FEMALES
PREGNANT FEMALES WITH FETAL ANOMALIES DETECTED ON USG
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO OBSERVE FOR CONVULSIONS POST ANTIEPILEPTIC TREATMENT DURING THE PERIOD PATIENT IS IN HOSPITALTimepoint: DURATION OF HOSPITAL STAY (1-2 WEEKS)
- Secondary Outcome Measures
Name Time Method OT APPLICABLETimepoint: NOT APPLICABLE